Hospital Blood Transfusion Committee: Standard Operating Procedure
Hospital Blood Transfusion Committee: Standard Operating Procedure
CVPH-PANTUKAN
Revised 2020
Republic of the Philippines
Provincial Government of Compostela Valley
PROVINCIAL ECONOMIC ENTERPRISE MANAGEMENT OFFICE
COMPOSTELA VALLEY PROVINCIAL HOSPITAL
Pantukan
Approval Sheet
Evangeline D. Hornido, MD
Chief of Hospital
Dr. Geli
Hospital Blood Transfusion Committee - Chairman
Administrative Officer
Chief Nurse
Table of Contents
Approval Sheet 1
Table of Contents 2
Overview 3
Functions of the Committee 4
Appointment, Composition, Meetings, Record for Review 8
General Guidelines 9
Policy #1 Prescription of Blood/Blood Components 10
Policy #2 Informed Consent 11
Policy #3 Request to Secure Blood/Blood Component
12
Policy #4 Blood Cold Chain 13
Policy #5 Receiving Facility – Nurse Station/Laboratory 14
Policy #6 Crossmatching 15
Policy #7 Storage of Blood 17
Policy #8 Issuance of Compatibility Result 18
Policy #9 Releasing of Blood Unit 19
Policy #10 Blood Return, Standby/Unused Blood, Blood Replacement 21
Policy #11 Issuance of Pooled Blood 23
Responsibilities of Clinicians in Blood Transfusion…………………………….
Responsibilities of Nurses in Blood Transfusion
Policy #12 Pre-transfusion Checks on Blood/Blood Products 24
Policy #13 Identification of Patient and the Blood/Blood Product 26
Policy #14 Blood Component Administration 27
Policy #15 Monitoring and Observation of Transfusion 28
General Guidelines 31
Responsibilities of Laboratory Personnel in Blood Transfusion 32
Guidelines in the Management of Transfusion Reactions 33
Febrile Transfusion Reactions 35
Allergic Blood Transfusion Reactions 36
Hemolytic Blood Transfusion Reaction 37
Circulatory Overload Reaction 38
Blood Transfusion Reaction due to Contaminated Blood 39
Blood Transfusion Reaction from Rapid Infusion of Massive Amount of Stored
Blood 40
Hypothermic Blood Transfusion Reaction 41
Laboratory Procedures in the Investigation of Blood Transfusion Reactions 42
Interpretation of Laboratory Results of Examinations Done to Investigate Blood Transfusion
Reactions 44
Checklist for Signs of Deterioration of Blood or Plasma 46
References 47
Effectivity Date:
Background: Blood Transfusion is acknowledged to be a therapy that involves risks, so that the
organization’s performance, monitoring and improvement program must address the use of
blood and blood components. A cross functional group of medical and support staff is tasked
with the responsibility to take the leadership role in promoting safe and effective blood banking
and transfusion practices.
General Objective: To understand the importance of monitoring the blood transfusion practices
of the hospital and maintain quality standards in the area.
Specific Objectives:
To formulate policies for blood transfusion therapy.
To assess the usage and practices in blood component therapy.
To review and analyze statistical reports of the Blood Station.
To evaluate clinical and laboratory reports of adverse reactions to blood transfusion.
To promote continuing education on blood donation and transfusion to all groups of
hospital staff.
To provide safe and adequate supply of blood and blood products.
To make recommendation and reports to the appropriate departments of the
laboratory, medical, nursing, and administrative services of the hospital.
To implement established policies of the committee.
January 2017
1. Establish policies for blood transfusion therapy. Formulate policies and guidelines, to be
approved by the Chief of Hospital and officers of the committee.
2. Enhance quality of patient care through objective assessment of on-going blood and
blood component therapy.
5. Promote continuing education in transfusion practices and guidelines to the hospital staff
for which they are intended.
- Indications for transfusion (Refer to Phil. Clinical Practice Guidelines for the
Rational Use of Blood & Blood Products)
- Component therapy (Refer to Phil. Clinical Practice Guidelines for the
Rational Use of Blood & Blood Products)
- Blood ordering schedule for elective surgery (Refer to Clinicians for the
MSBOS)
- Blood bank policies and procedures. (Refer to CVPH Blood Bank SOP)
- Quality Assurance (Refer to AABB Technical Manual 15th ed)
6. Assess the safety and adequacy of the blood supply, through Blood Usage Review
program to ensure all services and all major products are included in the review process.
7. Annual review of the written policies and procedures of the hospital transfusion services
to ensure they conform to the standards set by DOH.
January 2017
10. Promote avoidance of unnecessary transfusion thus ensure appropriate utilization of blood
components.
11. Implement and monitor blood component therapy for appropriate use of blood.
a. Ordering of blood/blood components
i. Create policies on:
o Blood transfusion in general
o Number of units to be requested (Refer to Indications of Blood/Blood
Component Transfusion (p.28-62, DOH Manual, Phil. CPG for the
Rational Blood Use/MSBOS)
o Disposition/release of unused crossmatched units
c. Utilization Review
Objectives:
o To maximize rational use of blood
o To minimize exposure to adverse effects of transfusion
o To minimize wastage of blood
January 2017
Procedure:
i. Set indication for use of various blood components
ii. Request for blood must state indication for component therapy
iii. Select scope and period for review of requests for blood transfusion
iv. Review of medical records of cases without justifiable indications in
the requests by chairman of the committee
v. Letter to attending physician / resident requesting explanation for
unjustifiable request.
vi. Explanation of attending Physician discussed by BTC
vii. Recommendation of BTC to department head.
viii. Periodic report of findings, actions and recommendation to proper
authorities
12. Integrate a plan for the management of blood shortages (in coordination with the Regional
Blood Services Network), including planning for the management of patients based on
predetermined categories (e.g. patients in need of immediate resuscitation, patients in need of
urgent surgical supports, non-surgical patients who are anemic, scheduled but non-emergency
surgical patients- refer to p28-62 DOH Manual, Phil. CPG for the Rational Blood Use).
13. Review operational effectiveness of the laboratory services (e.g. response time for
emergency request).
14. Review / evaluate transfusion reaction and medical errors with or without an adverse outcome.
January 2017
APPOINTMENT:
The committee is appointed by the Chief of Hospital. Appointment is for at least three (3) years.
COMPOSITION:
The committee is headed by an Internal Medicine Physician and vice-chaired by the Pathologist.
Support group members are the following: Chief of Hospital, representatives from the Medical
Staff, Chief Nurse and the Nurse Station Heads, Chief Medical Technologist/Blood Station-in-
charge, and the Administrative Officer. The committee chair is a Physician who is
knowledgeable in transfusion medicine.
Responsibilities:
Chairman
Vice Chair
Clinicians
Nurses/Medical Technologists
Administrative Staff
MEETINGS:
Meetings should be held at least quarterly or as often as necessary. Minutes of the meeting
must be written and maintained in detail to show date and time of convening, names of
members present and absent, business transacted, reports and their contents received, actions
taken, reports and recommendations to the Chief of Hospital, time of adjournment, and
signature of the chairman.
When liability issues are discussed, guests and other individuals who do not need to know
details are excused.
As part of its role in quality assurance and medical audit, all selected records of patients
discharged subsequent to the last committee meeting should be reviewed. Members do not
review their own records. Rates of results are tabulated for each physician, and appropriate
reports and recommendations are made to the Chief of Hospital.
Approval Date:
January 2017
Pre-established Criteria:
Guidelines for transfusion and blood banking, indications for transfusion, as well as guidelines
for ordering blood and its products and reporting, investigation and management of blood
transfusion reaction are pre-established in the hospital, approved by the Blood Transfusion
Committee.
All cases which are not consistent with the established criteria are reviewed by the Blood
Transfusion Committee as part of its role in quality assurance and medical unit.
1. Medical errors (with or without an adverse outcome) and adverse patient events related
to transfusion (tracked, analyzed for cause, categorized and managed).
2. Partially crossmatched units issued/transfused.
3. Excessive transfusions or indiscriminate use of blood.
4. Wrong indications of blood components.
5. Excessive turnaround time prior to issuing blood units.
6. Units returned unused/expired and discarded.
7. Overnight transfusion.
8. Surgical cancellation due to unavailability of blood.
9. Late requests for pre-operative /elective cases crossmatching.
10. Excessive requests for crossmatching.
11. Excessive emergency requests for blood.
12. High outdate rate due to:
a. Failure to notify the blood bank of cancelled surgical procedures.
b. Excessive notices of postponed procedures.
c. Failure of blood bank to follow “first to expire-first out” (FEFO) principle.
13. Cases with complications resulting from transfusion.
Approval Date:
A. Crossmatching and Overnight Transfusion
January 2017
The prescription of blood and blood components shall be the responsibility of the attending
physician.
Blood and blood components shall be prescribed in the Blood request form.
The form should be legibly filled up completely with all the pertinent data and should specify:
the urgency of the transfusion, including the date and time transfusion is to take place
the blood type, amount, and the blood component to be administered.
10
Routine blood transfusion shall commence only up to 10pm and shall be strictly implemented.
Cut-off time for routine blood unit withdrawal in the laboratory is at 6pm, and transfusion should
start within 30minutes from the blood unit withdrawal.
There are significantly increased risks to transfusing outside core hours so the transfusion
must be clinically ESSENTIAL. (Blood Transfusion Policy, Royal Cornwall Hospitals, 2014)
For WARD patients, if crossmatching and transfusion need to take place at night the reason for
this must be clearly stated in the patient notes, indicate in the request as “STAT Transfusion”
and a laboratory form on Acceptance of Responsibility (For Crossmatching and Transfusion
Beyond Core Hours) be signed by the requesting/attending physician and nurse-on-duty/nurse
attendant who will be responsible in closely monitoring the patient.
Approval Date:
January 2017
Procedure:
1. The Attending Physician makes a dialogue with the patient/watcher and informs them of the
significant risks, benefits and alternatives to transfusion including the patient’s right to refuse the
transfusion. As a result of this discussion the patient should:
a) Understand what medical action is recommended.
b) Be aware of the risks and benefits associated with the transfusion.
c) Appreciate the risks, and possible consequences of not receiving the recommended
therapy.
d) Be given an opportunity to ask questions.
e) Give consent for the transfusion.
2. The informed consent is valid during the entire admission period of the patient.
3. The nurse-on-duty provides the consent form for signature of the watcher/patient.
11
Approval Date:
January 2017
Policy#3. All requests to secure blood shall be prepared by the attending physician or the nurse
on duty in the prescribed form and signed legibly by the attending physician.
Procedure:
1. Accomplish the blood request with the exact amount of blood needed, blood type, indication
for transfusion, and then given to the patient/watcher for them to secure.
2. Advise the patient/watcher to proceed to the laboratory for further instructions on the
necessary procedures to secure blood from the blood bank, amount needed and proper
handling of blood bags.
Policy#3-A. STAT requests for blood shall be accomplished in the same prescribed form and
must be sent immediately to the blood bank through the watcher.
12
Approval Date:
January 2017
For other blood components like the platelet concentrate, fresh frozen plasma and
cryoprecipitate, coordinate first with Blood Station/Laboratory Personnel.
Approval Date:
January 2017
5. Receiving Facility
Nurse Station:
iv. The nurse-on-duty/nursing attendant withdraws the blood unit from the
laboratory for transfusion to the patient.
v. Observe proper transport, storage and documentation.
14
vii. Medical Technologist observes proper documentation, stores the blood and
issues a proof of blood deposit to the watcher.
viii. Watcher submits the blood deposit form to the nurse station.
Approval Date:
January 2017
1. The request for CROSSMATCHING shall be checked and all data shall be filled up correctly
and legibly including the serial number of the blood bag to be crossmatched and the name of
the physician and his signature checked.
2. Non-emergency request for blood must be sent to the blood bank/laboratory 24 hours prior to
the contemplated procedure.
3. Routine Crossmatching procedures are done during the morning and afternoon shift
only so that a co-identifier can re-check the processing and validate the result prior to release,
except for emergency cases.
4. Urgent request must be discussed directly by phoning the laboratory and the form should
then be labelled “URGENT” or “STAT”. All stat requests shall be attended to immediately.
5. In cases of extreme emergency, partially crossmatched blood may be released by the blood
bank only when the attending physician accepts responsibility for the risks involved in
transfusing such blood by signing the Acceptance of Responsibility form. The blood
bank/laboratory will notify the physician about the result once available. No compatibility label
should be attached upon release of the partially crossmatched blood pack.
15
6. The blood group of the patient must be determined using the ABO and Rh tube typing
method, and the results shall be validated by a co-identifier.
7. The patient and the donor shall be crossmatched using the 3-phase method.
8. All blood specimens for compatibility testing shall be extracted exclusively by any of the
laboratory personnel.
Approval Date:
January 2017
9. Plasma products (platelets, fresh frozen plasma, cryoprecipitate, cryosupernate) need not be
crossmatched, but retyped (using tube method) prior to release. Specific blood type products
shall be given. Please coordinate with the laboratory staff when plasma products are
needed so that specific instructions and further coordination with the Blood Center be
arranged.
10. Blood awaiting transfusion shall be kept in the blood bank refrigerator. For storage of whole
blood and packed red cells, it shall be kept at 1-6 OC. And the plasma freezer for storage of fresh
frozen plasma, cryoprecipitate, and cryosupernate at -30OC. Platelets are stored on a horizontal
shaker (agitator) with incubator. White cells “buffy coat” are used immediately and are not
refrigerated.
11. The blood station/laboratory staff shall be notified ASAP if surgery is cancelled/postponed.
12. The blood station/laboratory staff shall also be notified ASAP if the attending physician
decides that the blood transfusion is not needed anymore.
16
Approval Date:
January 2017
7. Storage of Blood
i. Any unit of blood obtained from outside (PNRC, or any other blood bank)
shall be brought directly by the watcher to the staff nurse in the ward who will
be responsible for delivering the blood to the blood bank/laboratory as soon
as possible or shall be brought directly by the watcher to the laboratory.
(Refer to Policy #5 on Receiving Facility-Nurse Station/Laboratory)
ii. The Medical Technologist-on-duty shall record all blood upon receipt after
checking the label which must contain the serial number, blood type, amount
of blood, extraction and expiration dates, and shall affix her signature after
noting the date and time the blood is received. Transmittal form which is
properly filled up by the Blood Bank Medical Technologist must be forwarded
together with the blood bag.
iii. Whole blood/PRBC must be stored only in blood bank refrigerator with
17
Note: CVPH Laboratories are still not capable of proper storage for other
blood components such as fresh frozen plasma, cryopecipitate,
cryosupernate, and platelet concentrate.
Approval Date:
January 2017
ii. Duplicate copies of the result will be made. It shall be attached to the
patient’s chart, and presented to the laboratory when crossmatched blood is
needed for transfusion.
18
Approval Date:
January 2017
i. Upon the request of the attending physician, except for massive transfusion,
only one unit of blood shall be issued at a time. When the attending
physician finds it necessary to get more than one unit, he shall be required to
sign a waiver/acceptance of responsibility form.
19
bank personnel will make an official result and endorse it to the concerned
party.
iii. The nurse picking-up the blood for use in the ward or other areas shall
present a copy of the result of the compatibility test. The medical technologist
issuing the blood and nurse withdrawing it shall both sign in the logbook.
Patient’s relatives are not authorized to pick-up blood from the laboratory.
Approval Date:
May 2016
iv. Before releasing the blood product, the laboratory staff shall check the
following:
Expiry date
ABO group
Serial number
Leaks at the ports and the seams
Evidence of hemolysis in the plasma or at the interface between red
cells and plasma.
Unusual discoloration or turbidity and the presence of large clots or
fibrin.
20
v. The transfusion form which is part of the compatibility result shall be signed
by the receiving nurse and the issuing medical technologist of the blood bag.
The necessary information will be completed in the ward by the nurse signed
by the resident-on-duty (ROD) and duplicate copy of which shall be sent to
the laboratory upon returning the used blood bag.
Approval Date:
January 2017
21
May 2016
iv. This applies only to the Hospital Blood Pool units. (for unused blood secured
by watcher from outside blood bank, inform the watcher to sign waiver of
voluntary donation of the blood unit)
Blood Replacement
22
Approval Date:
January 2017
Approval Date:
January 2017
All the following checks should be carried out at the bedside or otherwise adjacent to
the patient being transfused. Checking away from the patient/bedside, e.g. at the
Ward Office or desk, is a common and avoidable cause of transfusion accidents.
24
The surname, first name, date of birth and patient identification number should
be checked and found to be identical on:
Approval Date:
January 2017
25
Approval Date:
January 2017
26
2.1 Check the ABO and Rh group on the label of the blood container to be
certain that it also agrees with the Transfusion Record.
2.2 Check the number on the label of the blood container to be certain it agrees
with the Transfusion record.
DO NOT begin the transfusion until any discrepancy in the above information is
resolved.
Approval Date:
January 2017
before use and then transfused through an intravenous line approved for blood
administration incorporating a standard 170-200 micron filter. A peripheral vein cannula
18-20G size is recommended for adults while 22-24G is recommended for pediatric
patients. (Grade A; Level 2) Smaller gauge devices can be used but restrict the flow rate
of the transfusion and result in a much longer time to infuse a component. When blood is
being administered by syringe to small infants or neonates, the blood should be drawn
into the syringe via a 170-200 micron filter. (ANZSBT, 2004).
A new transfusion set should be used for every new unit of blood product. In an
emergency or operating room procedure where several units may be administered in a
short time, the transfusion set should be changed every 6 hours. A transfusion set used
for red cells should NOT be re-used for platelet transfusion since red cell debris trapped
in the filter would trap the platelets. (ANZSBT, 2004) (Grade A; level 3) (p71 Phil. CPG
for the Rational Use of Blood/Blood Products)
Intravenous Fluids
The standard set to be used in a blood transfusion should be primed with normal
saline (0.9 NSS) or the blood component. Dextrose containing solutions should
not be used for priming the blood transfusion set. The only fluids that can be
given concurrently through the same IV device as a red cell transfusion are: 1.
Normal saline, 2. 4% albumin, 3. Plasma protein fractions, or 4. ABO-compatible
plasma. Electrolyte and colloid solutions containing calcium or 5% dextrose
should not be given with blood components. (ANZSBT, 2004) (Grade A, Level 2)
Blood transfusion sets should not be ‘piggy-backed’ into other lines. Similarly
medication should not be added to any blood component prior to its transfusion.
Approval Date:
January 2017
28
The transfusion should be completed in less than 4 hours because of the dangers of bacterial
proliferation and red blood cell hemolysis at room temperature.
Approval Date:
January 2017
29
For each unit of blood transfused, monitor the patient at the following stages (Grade A; Level 3)
(WHO, 1997)
Before starting the transfusion
As soon as the transfusion is started
Every 15 minutes after starting the transfusion for first hour
Every 30 minutes during transfusion
On completion of the transfusion
Four hours after completing the transfusion
In each of these stages, record the following information on the patient’s chart:
Approval Date:
30
January 2017
Closer observation should take place for infants, unaccompanied children and patients
who are unable to verbalize symptoms or use the call bell due to mental or physical
limitations.
31
1. Make sure that requests to secure blood and compatibility test are properly and
completely filled up.
2. Take baseline vital signs.
3. Assure that blood is properly transported from the laboratory to the ward/unit and
observe the 30-minute rule.
4. Check label of blood bag against transfusion sheet.
5. Inspect thoroughly the blood pack of its general appearance and quality.
6. Set-up the transfusion.
7. Sign the transfusion sheets together with the attending physician
8. Recheck labels, type, compatibility results, expiry dates, and other pertinent data.
9. Should there be delays in hooking up the blood unit for transfusion, and the blood unit is
already in the ward, carefully monitor the time and adhere to the 30-minute rule for
blood unit/s taken out from the Blood Bank.
10. Ensure careful infusion.
11. Monitor patient during transfusion.
12. Report untoward reaction to attending physician.
13. Fill-up the report of blood transfusion reaction signed by the attending physician and
send this to the blood bank.
14. Keep records of progress of transfusion.
15. Keep records of number of blood units used by each patient.
16. Monitor wastage and improper use and handling of blood and report this to the Blood
Transfusion Committee.
17. Notify the laboratory if scheduled procedures are postponed or cancelled and when
reserved units are no longer needed.
32
1. Perform accurate compatibility testing and provide properly filled up result forms.
2. Assure that blood cold chain policy is implemented and blood units are properly stored
and transported from the laboratory to the ward/unit using an ice chest.
3. Inspect thoroughly the blood pack for its general appearance and quality before
issuance to the nurse.
4. Refer to the Pathologist for cases with difficult crossmatching and ABO/Rh typing
discrepancies.
5. Pathologist consults the clinician to further discuss the management of difficult typing,
crossmatching and transfusion cases.
January 2017
33
1. Any change in the patient’s condition while undergoing blood transfusion should be
recognized and evaluated. The nurse should remain with the patient while transfusing the
first 50mL of blood.
2. If a change in patient’s condition occurs, the flow of blood or component being administered
should be stopped, and the amount of blood which has been infused should be noted.
3. The vein should be kept open with starter solution (NSS) at a rate of 10-12 drops/minute, or
as directed.
4. Referral to the attending physician should be made immediately.
5. The reaction should be reported to the blood bank without delay.
6. The hospital form “Report of Transfusion Reaction” should be immediately filled up and
brought to the laboratory.
7. The blood bank number (serial number) on the blood bag should be checked with the
number on the blood transfusion sheet. The identification of the patient and other data
should be checked.
8. The remaining blood should be sent to the laboratory together with the blood transfusion set,
with the tubing clamped shut.
9. Any adverse symptoms or physical sign occurring during transfusion of blood or its’
components should be considered life-threatening. An adverse reaction is defined as any
unexpected outcome resulting either during or within several hours following the
blood transfusion. This includes, but it not limited to, any of the following:
a. Fever (rise of 1◦C or more)
b. Chills
c. Back pain
d. Dyspnea, including wheezing
e. Hypotension
f. Hemoglobinuria
g. Bleeding
34
January 2017
9.1 IMMEDIATELY STOP THE TRANSFUSION. Record the amount of blood which has
been infused.
9.2 Notify responsible physician
9.3 Keep I.V. line open with infusion of normal saline at a rate of 10-12 drops/minute or as
indicated.
9.4 Check all forms, labels, and patient identification to determine if the patient received the
correct blood or component.
9.5 Report the suspected transfusion reaction to blood bank personnel immediately
9.6 Send completed transfusion reaction form, discontinued bag of blood, administration set,
and all of the IV solutions to the blood bank.
9.7 The blood bank shall collect a blood sample for repeat crossmatching and other studies
for blood transfusion reaction, especially when a hemolytic blood transfusion is
suspected.
9.8 The nurse attendant should collect sample of the next urine and send it to the laboratory
for hemoglobin determination.
35
Approval Date:
January 2017
Signs and Symptoms: Chills, fever, headache, myalgia, nausea, and non-productive cough.
Onset: During transfusion or up to 24 hours post-transfusion.
History: Patients with multiple transfusion or pregnancies.
1. Stop the transfusion and note the amount of blood transfused.
2. Keep the vein open with NSS.
3. Notify physician
4. Give acetaminophen or aspirin if necessary. Treatment is generally not required
since symptoms resolve in a short period.
5. Report to the blood bank. Refer to CVPH HBTC SOP, p33, Guidelines for
Management of Transfusion Reaction.
6. The transfusion may be continued if the clinical signs and symptoms and
laboratory tests were able to rule out a hemolytic blood transfusion reaction.
36
January 2017
Signs and Symptoms: Skin rashes, flushing, and for extreme cases of anaphylaxis: nausea,
vomiting, and hypotension.
Onset: During transfusion or up to 24 hours post-transfusion.
History: Allergies
1. Stop transfusion and note the amount of blood transfused.
2. Keep vein open with NSS.
3. Notify physician.
4. Treatment is generally with antihistamine given orally or IM. Epinephrine or
steroid may be given for symptoms of acute asthma or anaphylaxis.
5. Report to the blood bank. Refer to CVPH HBTC SOP, p33, Guidelines for
Management of Transfusion Reaction.
37
January 2017
Signs and Symptoms: Apprehension, fever, chills, chest pain, headache, shock, nausea,
vomiting, dyspnea, flushing, oozing from minor wounds, or any
abnormal oozing of blood.
Onset: Immediate or delayed until up to 4th day or until several days after transfusion.
1. Stop the transfusion and note the amount of blood transfused.
2. Keep the vein open with NSS.
3. Notify the physician.
4. Treatment is aimed at preventing renal failure. Give mannitol IV push over 10-15
mins, followed by continuous infusion of 5% mannitol regulated to maintain urine
output at 100-150 cc/hr. Normal saline with Na bicarbonate may also be given.
5. Patients with suspected disseminated intravascular coagulopathy (DIC) may be
given heparin at 40-50 units IV/ lb. body weight over 4 hours.
6. Give ventilator support and intubation if indicated by hypotension and shock.
7. Report to the blood bank. Refer to CVPH HBTC SOP, p33, Guidelines for
Management of Transfusion Reaction.
38
January 2017
Signs and Symptoms: Cough shortness of breath, neck vein engorgement, rales, pulmonary
congestion and edema.
Onset: Gradual, within increasing severity of symptoms as more blood is infused.
History: Chronic anemia, infusion of massive volume of blood and/or fluid over a short period.
1. Stop the transfusion and note the amount of blood infused.
2. Keep vein open with NSS.
3. Notify physician.
4. Give oxygen if necessary.
5. Give diuretics.
6. Report to the blood bank. Refer to CVPH HBTC SOP, p33, Guidelines for
Management of Transfusion Reaction.
39
January 2017
40
Signs and Symptoms: Coagulation changes and bleeding, acidosis, and hypocalcemia.
History: Transfusions of blood near expiry date or near outdate.
1. Stop the transfusion and note the amount of blood infused.
2. Keep vein open with NSS.
3. Notify physician.
4. Check platelet count, PT, PTT. May give platelet concentrate and fresh frozen
plasma
5. Give NaHCO3 IV.
6. Check calcium level, do ECG and give CaCl2.
7. Report to the blood bank. Refer to CVPH HBTC SOP, p33, Guidelines for
Management of Transfusion Reaction.
41
January 2017
42
2. Examination of serum, for hemolysis and a direct Coomb’s test done on the post-
transfusion specimen for antibody coating of red cells.
3. The pre and post-transfusion samples are rechecked for blood group and immune
antibodies, and compatibility testing is repeated.
a. Repeat ABO and Rh test on both pre and post-transfusion samples, and on
blood taken from the bag or from a segment still attached to the unit.
b. Repeat the crossmatch on both the pre and post-transfusion samples against a
sample of red cells form the bag or from a segment still attached to the unit.
43
7. The patient’s history and the results of tests are evaluated by the blood bank physician
who makes an interpretation.
8. The blood bank physician notifies the physician-in-charge of the results and
interpretation of the investigation as soon as possible.
44
a. When ABO and Rh typing on the patient’s pre- and post-transfusion samples do
not agree, an error in either the patient identification, typing, or blood drawing is
considered.
b. When the ABO group of the blood specimen does not match with the ABO group
on the bag, an error in labelling is considered, and thus, an error in compatibility
test is also considered as well.
c. When results of pre- and post-transfusion specimens are not compatible, an error
during pre-transfusion testing is considered. (The donor specimen used for
compatibility test may have been taken from a different unit.)
45
a. If the free hemoglobin and bilirubin tests are both negative and the Coomb’s test
is positive, an acute immune hemolytic reaction is not considered. However, if
the patient’s clinical condition strongly suggests a hemolytic reaction, further
investigation is warranted.
b. If free hemoglobin is positive, bilirubin is negative, and the Coomb’s test is
positive, a conclusive interpretation is not possible, and the situation requires
further investigation. If free hemoglobin is negative, bilirubin is positive and
Coomb’s test is negative, a conclusive interpretation is likewise not possible, and
the situation also requires further investigation.
c. If free hemoglobin is positive, bilirubin is positive, and Coomb’s test is positive,
and acute immune hemolytic reaction is highly considered.
a. When the post-transfusion sample for ABO and Rh tests show a mixed field
pattern, the presence of incompatible donor cells is considered.
b. When the crossmatch is incompatible with the post-transfusion specimen but
compatible with the pre-transfusion specimen, an anamnestic response is
considered.
46
January 2017
Before blood/blood product is issued from the blood bank to end-users, it should always be
inspected for any signs of deterioration, including:
1. Any sign of hemolysis in the plasma indicating that the blood has been contaminated,
allowed freezing or becoming too warm.
2. Any sign of hemolysis on the line between the red cells and plasma. If you suspect this,
gently mix the unit and allow in to “settling out” before being issued.
3. Any sign of contamination, such as a change of color in the red cells, which often look
darker or purple/black when contaminated.
4. Any clots, which may mean that the blood was not mixed properly with the anticoagulant
when it was collected.
5. Any signs that there is a leak in the bag or that it has already been opened.
47
January 2017
Safe Blood and Blood Products, Introductory Module: Guidelines and Principle for Safe Blood
Transfusion Practice, World Health Organization, pages 58-59.
Philippine Clinical Practice Guidelines for the Rational Use of Blood and Blood Products and
Strategies for Implementation, Department of Health, 2010
48